Cardiology

Researchers discover new culprit in atherosclerosis

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published ...

Diabetes

Solving a genetic mystery in type 1 diabetes

In type 1 diabetes, the immune system attacks the body's own insulin-producing cells. Scientists understand reasonably well how this autoimmune attack progresses, but they don't understand what triggers the attack or how ...

Diabetes

Experimental compound counters diabetic complications

An experimental compound reduced complications of type 1 and type 2 diabetes in mice—not by lowering blood sugar—but by countering its consequences: cell death, inflammation, and organ damage.

Oncology & Cancer

Novel therapeutic strategy shows promise against pancreatic cancer

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of ...

Diseases, Conditions, Syndromes

Drug prevents multiple sclerosis relapses in phase 3 trial

A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common ...

Cardiology

New way to regenerate hearts after a heart attack

Researchers funded by the British Heart Foundation have identified how a new treatment in mice can regenerate the heart after a heart attack—preventing the onset of heart failure.

page 3 from 22